Published in Vaccine Weekly, July 18th, 2007
"Two IE surface molecules, VAR1CSA and VAR2CSA, bind CSA in vitro and are potential vaccine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2007-07-18)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.